Cancer is the second leading cause of death and illness in kidney transplant recipients. Managing it is challenging due to the need to balance cancer treatment with preserving graft function and reducing rejection risk. Immunosuppression affects cancer treatment efficacy, and adjusting the regimen can enhance anti-cancer immune responses. However, patients and physicians often hesitate to change immunosuppression due to concerns about rejection and graft loss. A multidisciplinary approach is crucial for managing these patients.
We bring you a KOL interview on the management of kidney cancer in transplant patients. Join our renowned Consultant Nephrologist and Transplant Physician Dr. Vilesh Valsalan Kalthoonical on 3 rd January 2025 , 6:00 PM IST onwards. Session highlights Shifting treatment landscape for kidney cancer Combining targeted therapy with immunotherapy Recommendations for…
